Post-approval studies (Phase 4)Study completedNCT00415103
What this trial is testing
AMENO-2: Aprepitant Plus Palonosetron Versus Granisetron in the Prevention of Nausea and the Emesis Induced by Chemotherapy in Patients Treated With Haematopoietic Progenitors
Who this might be right for
LeukemiaLymphoma
PETHEMA Foundation 196